Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19.
Niederwieser C, Weber B, Reichard M, Gagelmann N, Ajib S, Schlipfenbacher V, Zeng Z, Lang F, Janson D, Wolschke C, Ayuk F, Bug G, Kröger N. Niederwieser C, et al. Bone Marrow Transplant. 2022 Jul;57(7):1180-1182. doi: 10.1038/s41409-022-01660-3. Epub 2022 Apr 20. Bone Marrow Transplant. 2022. PMID: 35444233 Free PMC article. No abstract available.
Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
Christopeit M, Reichard M, Niederwieser C, Massoud R, Klyuchnikov E, Haase N, Wolschke C, Ayuk F, Heidenreich S, Kröger N. Christopeit M, et al. Among authors: niederwieser c. Bone Marrow Transplant. 2021 Jun;56(6):1478-1481. doi: 10.1038/s41409-021-01225-w. Epub 2021 Feb 9. Bone Marrow Transplant. 2021. PMID: 33564122 Free PMC article. No abstract available.
Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.
Niederwieser C, Starke S, Fischer L, Krahl R, Beck J, Gruhn B, Ebell W, Körholz D, Wößmann W, Bader P, Lang P, Al-Ali HK, Cross M, Eisfeld AK, Heyn S, Vucinic V, Franke GN, Lange T, Pönisch W, Behre G, Christiansen H. Niederwieser C, et al. Ann Hematol. 2016 Feb;95(3):473-81. doi: 10.1007/s00277-015-2569-7. Epub 2015 Dec 23. Ann Hematol. 2016. PMID: 26696465
Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria.
Benakli M, Ahmed Nacer R, Mehdid F, Belhadj R, Talbi A, Rahmoune N, Niederwieser C, Baazizi M, Akhrouf S, Ait Ouali D, Bouarab H, Zerkout S, Abderahim I, Harieche F, Hamladji RM. Benakli M, et al. Among authors: niederwieser c. Ann Hematol. 2020 Mar;99(3):619-625. doi: 10.1007/s00277-020-03914-w. Epub 2020 Jan 23. Ann Hematol. 2020. PMID: 31974679
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Scheller M, Ludwig AK, Göllner S, Rohde C, Krämer S, Stäble S, Janssen M, Müller JA, He L, Bäumer N, Arnold C, Gerß J, Schönung M, Thiede C, Niederwieser C, Niederwieser D, Serve H, Berdel WE, Thiem U, Hemmerling I, Leuschner F, Plass C, Schlesner M, Zaugg J, Milsom MD, Trumpp A, Pabst C, Lipka DB, Müller-Tidow C. Scheller M, et al. Among authors: niederwieser c. Nat Cancer. 2021 May;2(5):527-544. doi: 10.1038/s43018-021-00213-9. Epub 2021 May 25. Nat Cancer. 2021. PMID: 35122024
No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group.
Lange T, Niederwieser C, Gil A, Krahl R, von Grünhagen U, Al-Ali HK, Jentsch-Ullrich K, Spohn C, Lakner V, Assmann M, Junghanss C, Cross M, Hehlmann R, Deininger M, Pfirrmann M, Niederwieser D. Lange T, et al. Among authors: niederwieser c, niederwieser d. Leuk Lymphoma. 2020 Dec;61(12):2821-2830. doi: 10.1080/10428194.2020.1786556. Epub 2020 Jul 16. Leuk Lymphoma. 2020. PMID: 32672489 Clinical Trial.
20 results